INTERPRETATION OF CLINICAL-TRIALS IN DIFFUSE LARGE-CELL LYMPHOMA

被引：98

作者：

ARMITAGE, JO ^{[1
]}

CHESON, BD ^{[1
]}

机构：

[1] NCI, BETHESDA, MD 20205 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1988年 / 6卷 / 08期

关键词：

D O I：

10.1200/JCO.1988.6.8.1335

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1335 / 1347

页数：13

共 110 条

[1] HISTOLOGIC CONVERSION IN THE NON-HODGKINS LYMPHOMAS [J].

ACKER, B ;

HOPPE, RT ;

COLBY, TV ;

COX, RS ;

KAPLAN, HS ;

ROSENBERG, SA .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (01) :11-16

[2]

ANDERSON JR, 1987, P AN M AM SOC CLIN, V6, P198

[3]

ARMITAGE JO, 1981, CANCER TREAT REP, V65, P413

[4] AGGRESSIVE CHEMOTHERAPY FOR DIFFUSE HISTIOCYTIC LYMPHOMA IN THE ELDERLY - INCREASED COMPLICATIONS WITH ADVANCING AGE [J].

ARMITAGE, JO ;

POTTER, JF .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1984, 32 (04) :269-273

[5] CHEMOTHERAPY FOR DIFFUSE LARGE-CELL LYMPHOMA - RAPIDLY RESPONDING PATIENTS HAVE MORE DURABLE REMISSIONS [J].

ARMITAGE, JO ;

WEISENBURGER, DD ;

HUTCHINS, M ;

MORAVEC, DF ;

DOWLING, M ;

SORENSEN, S ;

MAILLIARD, J ;

OKERBLOOM, J ;

JOHNSON, PS ;

HOWE, D ;

BASCOM, GK ;

CASEY, J ;

LINDER, J ;

PURTILO, DT .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (02) :160-164

[6] LONG-TERM REMISSION DURABILITY AND FUNCTIONAL STATUS OF PATIENTS TREATED FOR DIFFUSE HISTIOCYTIC LYMPHOMA WITH THE CHOP REGIMEN [J].

ARMITAGE, JO ;

FYFE, MAE ;

LEWIS, J .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (08) :898-902

[7]

ARMITAGE JO, 1982, CANCER, V50, P1695, DOI 10.1002/1097-0142(19821101)50:9<1695::AID-CNCR2820500907>3.0.CO

[8]

2-H

[9]

BAUER KD, 1986, CANCER RES, V46, P3173

[10] YORKSHIRE-REGIONAL-LYMPHOMA-HISTOPATHOLOGY-PANEL - ANALYSIS OF 5 YEARS EXPERIENCE [J].

BIRD, CC ;

LAUDER, I ;

KELLETT, HS ;

CHORLTON, I ;

BARNES, N ;

DARWIN, C ;

CARTWRIGHT, RA ;

BOYKO, R .

JOURNAL OF PATHOLOGY, 1984, 143 (04) :249-258

← 1 2 3 4 5 6 7 8 9 10 →